Ai Yang

Ai Yang Uses, Dosage, Side Effects, Food Interaction and all others data.

Pegylated L-asparagine amidohydrolase from E. coli. Pegylation substantially (by a factor of 4) extends the protein half life.

In a significant number of patients with acute leukemia, the malignant cells are dependent on an exogenous source of asparagine for survival. Normal cells, however, are able to synthesize asparagine and thus are affected less by the rapid depletion produced by treatment with the enzyme asparaginase. Oncaspar exploits a metabolic defect in asparagine synthesis of some malignant cells.

Trade Name Ai Yang
Availability Prescription only
Generic Pegaspargase
Pegaspargase Other Names Peg-asparaginase, Peg/L-asparaginase, Pegaspargasa, Pegaspargase
Related Drugs methotrexate, doxorubicin, imatinib, Gleevec, mercaptopurine, Sprycel
Type
Formula C1377H2208N382O442S17
Weight 31731.9 Da
Groups Approved, Investigational
Therapeutic Class
Manufacturer
Available Country China
Last Updated: September 19, 2023 at 7:00 am
Ai Yang
Ai Yang

Uses

Ai Yang is a modified form of L-asparagine amidohydrolase used to treat acute lymphoblastic leukemia, which is dependent on an external source of asparagine.

For treatment of acute lymphoblastic leukemia

Ai Yang is also used to associated treatment for these conditions: Acute Lymphoblastic Leukaemias (ALL)

How Ai Yang works

Ai Yang, more effective than asparaginase, converts asparagine to aspartic acid and ammonia. It facilitates production of oxaloacetate which is needed for general cellular metabolism. Some malignant cells lose the ability to produce asparagine and so the loss of exogenous sources of asparagine leads to cell death.

Toxicity

Adverse effects that occur more than 10% of the time include hepatotoxicity as it is known to increase serum transaminases (ALT, AST). Also known to induce hypersensitivity reactions including anaphylaxis, erythema and bronchospasm.

Food Interaction

  • Avoid excessive or chronic alcohol consumption. Alcohol and pegaspargase can both cause hepatoxicity, therefore if they are used together they may have additive hepatoxic effects.

Ai Yang Alcohol interaction

[Moderate]

Concomitant use of asparaginase with other hepatotoxic agents may potentiate the risk of liver injury.

Asparaginase-associated hepatotoxicity has been reported more commonly in adults than in children and has been strongly associated with obesity.

Hepatomegaly, acute severe hepatotoxicity, and fatal liver failure have been reported with asparaginase treatment in adults.

Also, asparaginase may increase the toxicity of drugs bound to plasma proteins or metabolized by the liver.



The risk of additive hepatotoxicity should be considered when asparaginase is used with other hepatotoxic agents (e.g., alcohol, androgens, antituberculosis agents, azole antifungal agents, ACE inhibitors, macrolide antibiotics, nonsteroidal anti-inflammatory agents, nucleoside reverse transcriptase inhibitors, sulfonamides, thiazolidinediones, and statins).

Liver function tests should be monitored at regular intervals during asparaginase treatment with or without other hepatotoxic drugs.

Patients should be advised to seek medical attention if they experience potential symptoms of hepatotoxicity such as right upper quadrant pain, increasing abdominal size, fever, rash, itching, anorexia, nausea, vomiting, fatigue, malaise, dark urine, pale stools, and jaundice.

Volume of Distribution

IV: Adults (asparaginase naive): 2.4 L/m2 Distributes into CSF (reportedly reducing CSF asparagine concentrations to a similar extent as asparaginase

Elimination Route

Onset of Asparagine depletion by IM is within 4 days Time to peak: IM: 3 to 4 days

Half Life

IM: ~6 days; half-life decreased to ~3 days (range: 1.4 to 5 days) in patients with previous hypersensitivity to native L-asparaginase; IV: Adults (asparaginase naive): 7 days

Innovators Monograph

You find simplified version here Ai Yang

*** Taking medicines without doctor's advice can cause long-term problems.
Share